Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (66)
  • 2024 (84)
  • 2023 (102)
  • 2022 (93)
  • 2021 (67)
  • 2020 (17)
  • 2019 (10)
  • 2018 (4)

Subject

  • Drug Trafficking (4013)
  • Synthetic drugs (1065)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (604)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (457)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (6)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)
  • Money Laundering (203)

Drug Name

  • Fentanyl (79)
  • Cocaine (70)
  • Methamphetamine (61)
  • Opioids (42)
  • Oxycodone (38)
  • Heroin (32)
  • Marijuana (Cannabis) (16)
  • Hydromorphone (13)
  • Synthetic Opioids (13)
  • Benzodiazepines (7)
  • Morphine (6)
  • Amphetamines (3)
  • Ecstasy/MDMA (3)
  • Methadone (3)
  • Steroids (3)
  • Ketamine (2)
  • Marijuana Concentrates (2)
  • K2/Spice (1)
  • Psilocybin (1)

Field Division

  • New England (62)
  • Washington, DC (51)
  • St. Louis (38)
  • Houston (32)
  • New York (32)
  • Seattle (32)
  • Chicago (28)
  • Miami (26)
  • New Jersey (23)
  • Atlanta (22)
  • San Francisco (14)
  • Headquarters (13)
  • El Paso (10)
  • Dallas (9)
  • New Orleans (9)
  • Phoenix (9)
  • San Diego (9)
  • Rocky Mountain (7)
  • Los Angeles (5)
  • Louisville (5)
  • Detroit (4)
  • Omaha (3)
Clear All Results
PRESS RELEASE

South Carolina Man Pleads Guilty to Distributing Illegal Steroids

May 25, 2022
ABINGDON, Va. – The owner of a supplement company, that manufactured and shipped unapproved drugs and illegal steroids for use by members of the bodybuilding community, pled guilty this week to a pair of federal drug charges. John Franklin Cochcroft, 37, of Lexington, South Carolina, waived his right to be...
May 25, 2022
PRESS RELEASE

15 People Charged with Trafficking Semi-Truckloads of Marijuana and Laundering Drug Proceeds

May 20, 2022
INDIANAPOLIS – Michael J. Gannon, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Indianapolis, and U.S. Attorney Zachary A. Myers for the Southern District of Indiana announced that a federal grand jury has indicted 15 people on drug trafficking and money laundering charges. Specifically, the indictment charges the defendants...
May 20, 2022
PRESS RELEASE

Dominican Republic Citizen Extradited to the United States on Money Laundering Charges

May 20, 2022
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a citizen of the Dominican Republic, who was extradited to the United States on money laundering charges, made his...
May 20, 2022
PRESS RELEASE

Three Convicted in $500,000 Mexican Cartel Weapon Scheme

May 18, 2022
LAREDO, Texas – Three individuals have admitted to their roles in a conspiracy for Cartel del Noreste (CDN), announced Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux, Houston Division and U.S. Attorney Jennifer B. Lowery. Luis Ramos, 44, of Rio Bravo, Texas pleaded guilty today to conspiracy...
May 18, 2022
PRESS RELEASE

Mercer County Accounting Professor Charged with Tax Evasion and Filing False Tax Returns

May 12, 2022
TRENTON, N.J. – A Mercer County, New Jersey, man was arrested today for tax evasion and filing false tax returns, U.S. Attorney Philip R. Sellinger announced. Gordian A. Ndubizu, 67, of Princeton Junction, New Jersey, is charged in an eight-count indictment unsealed today with four counts of tax evasion and...
May 12, 2022
PRESS RELEASE

Former Mercer County Pharmacist Charged with Illegally Distributing Oxycodone and Other Opiates from Trenton Pharmacy

May 12, 2022
TRENTON, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former pharmacist was arrested today for her role in distributing and dispensing outside the course of professional practice...
May 12, 2022
PRESS RELEASE

Two Lebanese Citizens Extradited from Republic of Georgia to Face International Money Laundering Charges

May 02, 2022
Brooklyn, N.Y. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the Eastern District of New York Breon Peace announced two citizens of Lebanon, Mohamad Yassine and Hassan Rahman, will be arraigned today on money laundering charges for operating...
May 02, 2022
PRESS RELEASE

Thermo Fisher Scientific Chemicals Acknowledges Recordkeeping Violations Of The Controlled Substances Act

May 02, 2022
BOSTON – Thermo Fisher Scientific Chemicals, Inc., an affiliate of the Waltham-based Thermo Fisher Scientific, Inc. (Thermo Fisher), has agreed to pay $25,000 to resolve allegations that it violated the Controlled Substances Act, by improperly purchasing and distributing chemicals regulated by the Act. Thermo Fisher self-disclosed these violations to the...
May 02, 2022
PRESS RELEASE

Wisconsin Pharmacy to Pay Civil Penalty for Controlled Substance Dispensing and Record Keeping Violations

April 29, 2022
MADISON, Wis. – John G. McGarry, Assistant Special Agent in Charge of Drug Enforcement Administration-Wisconsin, and U.S. Attorney Timothy M. O’Shea, of the Western District of Wisconsin, announced today that Cadott Miller Pharmacy, Ltd., located in Cadott, Wisconsin, entered into a settlement agreement to pay $20,000 to resolve civil allegations...
April 29, 2022
PRESS RELEASE

DEA Chicago Suspends Registration of Suburban Chicago Pharmacy

April 28, 2022
CHICAGO – Robert Bell, Special Agent in Charge of the U.S. Drug Enforcement Administration - Chicago Division, announced that on April 27, 2022, DEA Chicago Diversion Investigators delivered an Immediate Suspension Order to Evergreen Park Pharmacy, located at 2850 W. 95th Street, Suite 100, Evergreen Park, Illinois, suspending its DEA...
April 28, 2022
Showing 301 - 310 of 443 results

Pagination

  • First page «
  • Previous page ‹
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Current page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster